summary
Introduced
01/13/2026
01/13/2026
In Committee
01/16/2026
01/16/2026
Crossed Over
Passed
Dead
03/13/2026
03/13/2026
Introduced Session
2026 Regular Session
Bill Summary
An act relating to health care coverage; amending s. 1.01, F.S.; defining the term “Joint Legislative Committee on Medicaid Oversight”; creating s. 11.405, F.S.; establishing the Joint Legislative Committee on Medicaid Oversight for specified purposes; providing for membership, subcommittees, and meetings of the committee; specifying duties of the committee; authorizing the committee to submit periodic reports to the Legislature; requiring the Auditor General and the Agency for Health Care Administration to enter into and maintain a data sharing agreement for a certain purpose by a specified date; requiring the Auditor General to assist the committee by providing certain staff or consulting services; requiring state agencies, political subdivisions of the state, and entities contracted with state agencies to give the committee access to certain records, papers, and documents; authorizing the committee to compel testimony and evidence according to specified provisions; providing for additional powers of the committee; providing that certain joint rules of the Legislature apply to the proceedings of the committee; requiring the agency to notify the committee of certain changes and provide a report containing specified information to the committee; requiring the agency to submit a copy of certain reports to the committee; amending s. 409.962, F.S.; defining terms; amending s. 409.967, F.S.; revising encounter data reporting requirements for prepaid Medicaid plans; requiring that the agency’s analysis of such encounter data include identification of specified occurrences; requiring the agency to use such analysis in setting managed care plan capitation rates; requiring that managed care plan contracts require any third-party administrative entity contracted with the plan to adhere to specified requirements; specifying additional types of payments which may not be included in calculating income for purposes of the achieved savings rebate; requiring, rather than authorizing, the agency to calculate the medical loss ratio for all managed care plans under certain circumstances; revising requirements for the calculation of medical loss ratios; requiring the agency to report medical loss ratios quarterly and annually for each managed care plan to the Governor and the Legislature within a specified timeframe; requiring the agency to ensure oversight of affiliated entities and related parties paid by managed care plans; requiring the agency to examine specified records and data related to such entities and parties; requiring the agency to consider certain data and findings when developing managed care plan capitation rates; revising the income sharing ratios used to calculate the achieved savings rebate beginning on a specified date; creating s. 409.9675, F.S.; requiring managed care plans to report to the agency and the Office of Insurance Regulation the existence of and specified details relating to certain affiliations by a specified date and annually thereafter; requiring managed care plans to report any change in such information to the agency and the office in writing within a specified timeframe; requiring the agency to calculate, analyze, and publicly report on the agency’s website an assessment of affiliated entity payment transactions in the Medicaid program and certain administrative costs by a specified date and annually thereafter; providing requirements for the assessment; amending s. 626.8825, F.S.; defining the term “affiliated manufacturer”; revising the definition of the term “pharmacy benefits plan or program”; revising requirements for contracts between a pharmacy benefit manager and a participating pharmacy; revising the frequency of and deadlines for certain reports pharmacy benefit managers are required to submit to the office beginning on a specified date; amending s. 626.8827, F.S.; revising and specifying additional practices pharmacy benefit managers are prohibited from engaging in; amending s. 627.42392, F.S.; conforming a cross-reference; providing effective dates.
AI Summary
This bill establishes a Joint Legislative Committee on Medicaid Oversight, comprised of five senators and five representatives, to ensure the Medicaid program operates efficiently and transparently, with duties including evaluating program financing, quality of care, and administrative functions, and identifying policies to control spending while improving health outcomes. The committee will have access to state agency records and can compel testimony, and the Auditor General will assist with staff and consulting services, including actuarial expertise. The bill also revises requirements for managed care plans, including stricter encounter data reporting for prepaid Medicaid plans, requiring analysis of this data to set capitation rates, and mandates that managed care contracts require third-party administrators to adhere to the same requirements as the plans themselves. Furthermore, it expands the definition of "affiliate" and "control" to better track relationships within the healthcare system, restricts certain payments to affiliates from being included in calculations for achieved savings rebates, and requires the agency to calculate and report medical loss ratios (MLRs), which represent the percentage of premium revenue spent on medical care, for all managed care plans, while also enhancing oversight of affiliated entities and related parties paid by these plans. The bill also introduces new reporting requirements for managed care plans regarding affiliations and mandates the agency to publicly report on affiliated entity payment transactions and administrative costs within the Medicaid program. Finally, it amends regulations for pharmacy benefit managers (PBMs), defining "affiliated manufacturer," revising contract requirements between PBMs and pharmacies to prevent certain financial clawbacks and ensure fair reimbursement, and prohibiting PBMs from owning or investing in affiliated manufacturers or reimbursing pharmacies less than their affiliates.
Committee Categories
Budget and Finance
Sponsors (7)
Jason Brodeur (R)*,
Alexis Calatayud (R),
Don Gaetz (R),
Ileana Garcia (R),
Gayle Harrell (R),
Ralph Massullo (R),
Darryl Rouson (D),
Other Sponsors (2)
Appropriations (Senate), Health Policy (Senate)
Last Action
Laid on Table, refer to CS/HB 697 (on 03/10/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.flsenate.gov/Session/Bill/2026/1760 |
| BillText | https://www.flsenate.gov/Session/Bill/2026/1760/BillText/c2/HTML |
| Analysis - Appropriations (Post-Meeting) | https://www.flsenate.gov/Session/Bill/2026/1760/Analyses/2026s01760.ap.PDF |
| Analysis - Appropriations (Pre-Meeting) | https://www.flsenate.gov/Session/Bill/2026/1760/Analyses/2026s01760.pre.ap.PDF |
| BillText | https://www.flsenate.gov/Session/Bill/2026/1760/BillText/c1/HTML |
| Analysis - Health Policy (Post-Meeting) | https://www.flsenate.gov/Session/Bill/2026/1760/Analyses/2026s01760.hp.PDF |
| https://www.flsenate.gov/Session/Bill/2026/1760/Amendment/620456/HTML | |
| Analysis - Health Policy (Pre-Meeting) | https://www.flsenate.gov/Session/Bill/2026/1760/Analyses/2026s01760.pre.hp.PDF |
| BillText | https://www.flsenate.gov/Session/Bill/2026/1760/BillText/Filed/HTML |
Loading...